A Phase I Trial With Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 03 Oct 2017
At a glance
- Drugs Oxaliplatin (Primary)
- Indications Colon cancer
- Focus Adverse reactions
- 25 Sep 2017 Planned primary completion date changed from 1 May 2018 to 1 May 2019.
- 25 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 28 Jul 2016 Status changed from active, no longer recruiting to recruiting.